Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
Date:11/5/2009

PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2009.

Total revenues for the third quarter of 2009 were $30.8 million, compared to $17.7 million for the quarter ended September 30, 2008. XYREM® (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, and represented a 12% sequential increase over net sales of $22.4 million for the second quarter of 2009. Net sales of once-daily LUVOX CR® (fluvoxamine maleate) extended-release capsules were $5.0 million for the third quarter of 2009, compared to $2.0 million for the third quarter 2008, and represented a 20% sequential increase over net sales of $4.1 million for the second quarter of 2009. Total revenues for the third quarter of 2009 also included $0.8 million in royalties and contract revenue.

"Our sales team delivered another solid quarter for us with record numbers of XYREM and LUVOX CR prescriptions and net sales" said Bob Myers, President of Jazz Pharmaceuticals.

Research and development expenses for the third quarter of 2009 were $7.6 million, compared to $12.1 million for the third quarter of 2008. This reduction from $11.2 million for the second quarter of 2009 was primarily due to the completion of the second Phase III pivotal clinical efficacy trial for JZP-6, sodium oxybate for the treatment of fibromyalgia, in June of 2009. Jazz Pharmaceuticals expects to submit a New Drug Application for JZP-6 by the end of 2009.

Jazz Pharmaceuticals' net loss for the third quarter of 2009 was $1.7 million, compared to a net loss of $28.8 million for the third quarter of 2008.

Jazz Pharmaceuticals is increasing its full-year 20
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/21/2014)... , Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... priced its offering of $80,000,000 aggregate principal amount of ... in a private offering within the United ... qualified institutional buyers pursuant to Rule 144A under the ... Lexicon has also granted the initial purchasers an option ...
(Date:11/18/2014)... 2014 Respiratory Motion and IMI Co announced ... and services providers in Japan , ... innovative respiratory depression monitor, the ExSpiron™. As part of ... together to connect the clinical community in promoting patient ... bringing innovative medical devices and new technology to the ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... Sept. 23, 2011 A pharmaceutical company,s marketing strategy ... introducing a new brand in a space where the ... two-thirds of companies, the most frequent changes require shifting ... activities, such as professional relations, promotional literature, sampling, and ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Company intends to release its third quarter 2011 financial results ... the U.S. financial markets.  The Company will also host a ... November 1, 2011 to discuss its financial results and provide ...
Cached Medicine Technology:Pharmaceutical Marketing Strategy Balances Support Between New & Established Products in the Same Indication 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings 2
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- The cost of ... percent in recent years, climbing to more than $322 ... increases in cost were seen with prediabetes care, which ... jumped 82 percent, the researchers added. In 2012, ... totaled more than $1,000 for every American. That total ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 Big ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , Big Bud Farms, growers ... for growing, harvesting, and utilization of medical marijuana. , ... Big Bud Farms’ wide variety of products for medicating. ...
(Date:11/21/2014)... 21, 2014 Midway through the research ... Inc.’s (AIS) annual Directory of Health Plans, preliminary data ... Directory of Health Plans is a comprehensive resource with ... in the U.S. The 2015 edition will ... AIS’s Directory and Databases Division, the company’s exclusive in-house ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer ... fashion accessories. Furthermore, the company has launched its Special Black ... all its fashion items. Also, orders above $59 are qualified ... company, their wedding dresses and prom dresses are very popular ... rates. , The CEO says “We are glad to ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2
... risk of tooth decay as it damages the tooth enamel due ... risk of tooth decay which cannot be repaired if affected//. The ... fizzy drinks can be reduced. ,Using a straw can ... positioned to the inside of the mouth which reduces the contact ...
... Public Health says that low income groups and those with ... diseases//. The study arrived at these conclusions after analyzing data ... Maryland. ,The researchers say that a person's income ... bleeding gums and that a person with low income was ...
... care system, after widespread devastation by the Tsunami that stuck ... individuals lost their lives and a million others were injured ... great help in the process of rejuvenation of the health ... part of the health care system in Indonesia. Infact 80 ...
... In a new study that is to appear in ... Hopkins researcher suggests that cancers might begin with epigenetic ... occur in individuals whose genes have been altered by ... changes occur in the development of cancers, but there ...
... identified two genes essential for the development of muscles.Da-Zhi Wang ... Chapel Hill // said that the genes are among a ... years ago. ,Only in the past few years ... multi-cellular organisms, including humans, the study authors said in an ...
... of using private hospital costs as a ruse to put ... // . ,Private health insurers are believed to have ... approve an annual premium increase of between 5 per cent ... be their fifth successive rise at double the inflation rate. ...
Cached Medicine News:Health News:Indonesian Health Care System Rebuilt After Tsunami 2Health News:Cancer Begins With Epigenetic Changes: Study 2Health News:Australian Health funds stand accused 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: